SLCO1B1 and myopathy: A meta-analysis of 14 studies with 3265 patients with myopathy compared to 7743 controls without myopathy found that the risk of myopathy in patients taking a statin was increased if they had gene variants SLCO1B1 521CC (OR 2.31, 95% CI 1.15–4.63, p = 0.019) or 521TC (OR 1.34, 95% CI 1.02–1.76, p = 0.034) or the combination of 521CC and 5221TC (OR 1.82, 95% CI 1.32–2.51, p < 0.001).